Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Assets
Cash and due from financial institutions	$ 4,617	$ 4,399
Federal funds sold and cash equivalents	35,113	66,321
Total cash and cash equivalents	39,730	70,720
Investment securities available for sale, at fair value	43,306	44,854
Investment securities held to maturity (fair value of $2,433 at March 31, 2017 and $2,411 at December 31, 2016)	2,235	2,224
Total investment securities	45,541	47,078
Loans held for sale	1,542	0
Loans, net of unearned income	885,089	851,953
Less: Allowance for loan losses	(15,475)	(15,580)
Net loans	869,614	836,373
Accrued interest receivable	3,225	3,117
Premises and equipment, net	5,176	5,197
Other real estate owned (OREO)	9,829	10,528
Restricted stock, at cost	4,658	4,658
Bank owned life insurance (BOLI)	24,704	24,544
Deferred tax asset	10,439	10,746
Other assets	1,930	3,224
Total Assets	1,016,388	1,016,185
Deposits
Noninterest-bearing deposits	61,840	92,535
Interest-bearing deposits	725,206	696,159
Total deposits	787,046	788,694
FHLBNY borrowings	79,650	79,650
Subordinated debentures	13,403	13,403
Accrued interest payable	620	655
Other liabilities	5,970	6,693
Total liabilities	886,689	889,095
Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B - non-cumulative convertible; Outstanding March 31, 2017 19,903 shares December 31, 2016 20,000 shares	19,903	20,000
Common stock, $.10 par value; authorized 15,000,000 shares; Issued: 7,172,986 shares at March 31, 2017 and 7,147,952 at December 31, 2016	716	715
Additional paid-in capital	62,488	62,300
Retained earnings	49,955	47,483
Accumulated other comprehensive income (loss)	(303)	(349)
Treasury stock, 284,522 shares at March 31, 2017 and 284,522 shares at December 31, 2016, at cost	(3,015)	(3,015)
Total shareholders’ equity	129,744	127,134
Noncontrolling interest in consolidated subsidiaries	(45)	(44)
Total equity	129,699	127,090
Total liabilities and equity	$ 1,016,388	$ 1,016,185